Fatal intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014

Journal of Analytical Toxicology

Volumn 39, Issue 8, 2015, Pages 602-606

  Shanks, Kevin G ^a   Sozio, Thomas ^b   Behonick, George S ^a  

^a AIT Laboratories   (United States)

^b Marion County Prosecutor's Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYDRONABINOL; 2 (4 BROMO 2,5 DIMETHOXYPHENYL) N [(2 METHOXYPHENYL)METHYL]ETHANAMINE; 2 (4 IODO 2,5 DIMETHOXYPHENYL) N [(2 METHOXYPHENYL)METHYL]ETHANAMINE; ACETONITRILE; CAFFEINE; DRONABINOL; PHENETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG; 2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-((2-METHOXYPHENYL)METHYL)ETHANAMINE; 2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE; ANISOLE DERIVATIVE; HOMOVERATRYLAMINE;

ACID ASPIRATION; ACID PRECIPITATION; ADOLESCENT; ADULT; ANALYTIC METHOD; ARM; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BRAIN EDEMA; BRONCHUS; CASE REPORT; CAUSE OF DEATH; COLLAPSE; CONTUSION; DISEASE ASSOCIATION; DRUG FATALITY; DRUG INTOXICATION; EMERGENCY CARE; HEART BLOOD VESSEL; HUMAN; HUMAN TISSUE; INGESTION; KNEE; LACERATION; LUNG EDEMA; LUNG LOBE; MALE; MEDICAL HISTORY; NECK; PHYSICAL EXAMINATION; SKIN ABRASION; TANDEM MASS SPECTROMETRY; THORAX; TOXICITY TESTING; TRACHEOBRONCHIAL TREE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNITED STATES; URINALYSIS; WOUND DEHISCENCE; ANALOGS AND DERIVATIVES; BLOOD; FORENSIC TOXICOLOGY;

ADOLESCENT; ANISOLES; DIMETHOXYPHENYLETHYLAMINE; FORENSIC TOXICOLOGY; HUMANS; MALE; PHENETHYLAMINES;

EID: 84943766018     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkv058     Document Type: Article

References (17)

1. Heim, R. (2003) Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure. Ph.D. thesis. Free University, Berlin, Germany.
2. Braden, M.R., Parrish, J.C., Naylor, J.C., Nichols, D.E. (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Molecular Pharmacology, 70, 1956-1964.
3. Ettrup, A., Hansen, M., Santini, M.A., Paine, J., Gillings, N., Palner, M. et al. (2011) Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT(2A) agonist PET tracers. European Journal of Nuclear Medicine and Molecular Imaging, 38, 681-693.
4. Zuba, D., Sekula, K., Buczek, A. (2013) 25C-NBOMe-new potent hallucinogenic substance identified on the drug market. Forensic Science International, 227, 7-14.
5. Zuba, D., Sekula, K. (2013) Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs. Drug Testing and Analysis, 5, 634-645.
6. Drug Enforcement Administration. (2013) Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Federal Register, 78, 221.
7. Shanks, K.G., Dahn, T., Terrell, A.R. (2012) Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. Journal of Analytical Toxicology, 36, 145-152.
8. Kelly, A., Eisenga, B., Riley, B., Judge, B. (2012) Case series of 25I-NBOMe exposures with laboratory confirmation. Clinical Toxicology (Philadelphia), 50, 702.
9. Rose, S.R., Poklis, J.L., Poklis, A. (2013) A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clinical Toxicology (Philadelphia), 51, 174-177.
10. Stellpflug, S.J., Kealey, S.E., Hegarty, C.B., Janis, G.C. (2014) 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. Journal of Medical Toxicology, 10, 45-50.
11. Poklis, J.L., Nanco, C.R., Troendle, M.M., Wolf, C.E., Poklis, A. (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)-methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Testing and Analysis, 6, 764-769.
12. Tang, M.H., Ching, C.K., Tsui, M.S., Chu, F.K., Mak, T.W. (2014) Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clinical Toxicology (Philadelphia), 52, 561-565.
13. Laskowski, L.H., Elbakoush, F., Calvo, J., Exantus-Bernard, G., Fong, J., Poklis, J.L. et al. (2014) Evolution of the NBOMes: 25C- and 25B-sold as 25I-NBOMe. Journal of Medical Toxicology, DOI: 10.1007/s13181-014-0445-9
14. Hill, S.L., Doris, T.,Gurung, S.,Katebe, S., Lomas, A., Dunn, M. et al. (2013) Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clinical Toxicology, 51, 487-492.
15. Poklis, J.L., Clay, D.J., Poklis, A. (2014) High performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens. Journal of Analytical Toxicology, 39, 113-121.
16. Poklis, J.L., Devers, K.G., Arbefeville, E.F., Pearson, J.M., Houston, E., Poklis, A. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Science International, 234, e14-e20.
17. Walterscheid, J.P., Phillips, G.T., Lopez, A.E., Gonsoulin, M.L., Chen, H.H., Sanchez, L.A. (2014) Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. American Journal of Forensic Medicine and Pathology, 35, 20-25.